Free Trial

Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year High - What's Next?

Pharma Mar logo with Medical background

Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $88.24 and last traded at $88.24, with a volume of 4000 shares changing hands. The stock had previously closed at $75.00.

Pharma Mar Trading Up 17.7 %

The stock's 50-day simple moving average is $79.25 and its 200-day simple moving average is $60.13. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.

Pharma Mar Company Profile

(Get Free Report)

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.

Recommended Stories

Should You Invest $1,000 in Pharma Mar Right Now?

Before you consider Pharma Mar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharma Mar wasn't on the list.

While Pharma Mar currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines